Back
Corporate News
Mahamaya Lifesciences to review financial results at board meeting on November 13, 2026
05-Nov-2026, 06:30
Mahamaya Lifesciences Limited will hold a board meeting on November 13, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the half year ended September 30, 2026, according to a regulatory filing. The trading window for the company's equity shares has been closed since October 1, 2026, and will reopen on November 16, 2026, in accordance with SEBI regulations.
